Insurance Coverage of Biosimilars: How Prior Authorization and Tier Placement Block Affordability
Biosimilars can cut biologic drug costs by up to 33%, but insurance rules like prior authorization and identical tier placement block real savings. Here’s how the system works-and why patients still pay nearly full price.
Continue Reading